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Abstract
Background
In Mozambique, schistosomiasis is highly endemic across the whole country. The Schisto-
somiasis Consortium for Operational Research and Evaluation (SCORE) coordinates a
five-year study that has been implemented in various African countries, including Mozam-
bique. The overall goal of SCORE was to better understand how to best apply preventive
chemotherapy with praziquantel (PZQ) for schistosomiasis control by evaluating the impact
of alternative treatment approaches.
Methods
This was a cluster-randomised trial that compared the impact of different treatment stra-
tegies in study areas with prevalence among school children of21% S. haematobium
infection by urine dipstick. Each village was randomly allocated to one of six possible combi-
nations of community-wide treatment (CWT), school-based treatment (SBT), and/or drug
holidays over a period of four years, followed by final data collection in the fifth year. The
most intense intervention arm involved four years of CWT, while the least intensive arm
involved two years of SBT followed by two consecutive years of PZQ holiday. Each study
arm included 25 villages randomly assigned to one of the six treatment arms. The primary
outcome of interest was change in prevalence and intensity of S. haematobium among 100
children aged 9-to-12-years that were sampled each year in every village. In addition to chil-
dren aged 9-to-12 years, 100 children aged 5–8 years in their first-year of school and 50
adults (aged 20–55 years) were tested in the first and final fifth year of the study. Prevalence
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and intensity of S. haematobium infection was evaluated by two filtrations, each of 10mL,
from a single urine specimen.
Principal findings
In total, data was collected from 81,167 individuals across 149 villages in ten districts of
Cabo Delgado province, Northern Mozambique. Overall PZQ treatment resulted in a signifi-
cant reduction in the prevalence of S. haematobium infection from Year 1 to Year 5, where
the average prevalence went from 60.5% to 38.8%, across all age groups and treatment
arms. The proportion of those heavily infected also reduced from 17.6% to 11.9% over five
years. There was a significantly higher likelihood of males being infected than females at
baseline, but no significant difference between the sexes in their response to treatment. The
only significant response based on a study arm was seen in both the 9-to-12-year-old and
first-year cross sections, where two consecutive treatment holidays resulted in a signifi-
cantly higher final prevalence of S. haematobium than no treatment holidays. When the
arms were grouped together, four rounds of treatment (regardless of whether it was CWT or
SBT), however, did result in a significantly greater reduction in S. haematobium prevalence
than two rounds of treatment (i.e. with two intermittent or consecutive holiday years) over a
five-year period.
Conclusions
Although PC was successful in reducing the burden of active infection, even among those
heavily infected, annual CWT did not have a significantly greater impact on disease preva-
lence or intensity than less intense treatment arms. This may be due to extremely high start-
ing prevalence and intensity in the study area, with frequent exposure to reinfection, or
related to challenges in achieving high treatment coverage More frequent treatment had a
greater impact on prevalence and intensity of infection when arms were grouped by number
of treatments, however, cost efficiency was greater in arms only receiving two treatments.
Finally, a significant reduction in prevalence of S. haematobium was seen in adults even in
the SBT arms implying the rate of transmission in the community had been decreased, even
where only school children have been treated, which has significant logistical and cost-sav-
ing implications for a national control programme in justifying CWT.
Author summary
Urogenital schistosomiasis is highly endemic in Mozambique. This study was part of a
multi-country trial, including Mozambique, designed to understand the impact of differ-
ent schistosomiasis treatment strategies involving community-wide treatment (CWT),
school-based (SBT), and treatment holidays over a five-year period. Results from Mozam-
bique showed that although preventive chemotherapy was successful in reducing the prev-
alence of Schistosoma haematobium over five-years, the most intense treatment approach,
annual CWT, did not have a significantly greater impact than less intense treatment strat-
egies, such as bi-annual SBT. Infection rates were higher among males, but there was no
difference in response to treatment by gender. Four rounds of treatment (regardless of
whether it was given in the community or school) did result in a significantly greater
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reduction of S. haematobium prevalence than two rounds of treatment over a five-year
period. There was, however, a resurgent increase in prevalence and intensity of S. haema-
tobium infection shown after two consecutive treatment-holiday years, implying a bounce
back in infection after a two year pause in treatment. Interestingly and unexpectedly,
there was a significant reduction in prevalence of schistosomiasis in adults even in com-
munities that had received SBT implying the force of transmission in the community had
been decreased, even where only school children had been treated. These findings provide
an evidence-base with significant logistical and cost-saving implications for programmatic
decisions on how best to gain control of Schistosoma haematobium.
Introduction
Schistosomiasis is a major yet neglected public health problem, second only to malaria in
terms of parasite-induced human morbidity and mortality worldwide [1]. Estimates show that
globally at least 218 million people required preventive treatment in 2015 [2–4], and at least 20
million suffer from severe and debilitating forms of the disease [5]. Schistosomiasis is a major
public health problem in Mozambique, as shown by an epidemiological survey of schistosomi-
asis and soil-transmitted helminthiasis among school children carried out between 2005 and
2007 [6]. The mean estimated prevalence of urogenital schistosomiasis, Schistosoma haemato-
bium, was 47% while that of intestinal schistosomiasis, S. mansoni, was much lower (around
1%) across all of Mozambique. In Cabo Delgado province, the area where this study took
place, the prevalence of S. haematobium was 57.9%, ranging from 8.8% on the coast to 93%
inland [6].
In 2001, the World Health Organisation (WHO) endorsed preventive chemotherapy (PC)
as the global strategy to control morbidity due to schistosomiasis through regular treatment
with praziquantel (PZQ) [7]. Treating all school-aged children (SAC) is more cost-effective
than a test-and-treat approach [8, 9], which is achieved by allocating a geographic area (typi-
cally the district) to a recommended WHO treatment category for schistosomiasis based on
infection prevalence [7]. As a result, most programmes control morbidity associated with
schistosomiasis through school-based deworming, as it is highly cost-effective [10]. However,
the limitation of this approach is poor coverage among out-of-school children, particularly
older children and those living far from schools, and neglecting children younger than four
years and adults [11]. Studies have highlighted the advantages of a community-wide treatment
(CWT) approach in addition to a school-based treatment (SBT) in reducing prevalence and
intensity of schistosomiasis infection, particularly in communities where not all children
attend school [11–15]. Furthermore, questions remain about optimal frequency of PZQ treat-
ment for infection and morbidity control. It has been observed in some studies that more fre-
quent dosing can improve reductions in worm burden and increase parasitological cure,
particularly where schistosomiasis is highly endemic [16]. Whereas others have shown that a
single dose of PZQ results in sustained low transmission of S. haematobium for two years [17].
The Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) was
established in 2008 to answer strategic questions about schistosomiasis control [18]. It includes
multi-country field studies that aim to understand the benefits and costs of alternative ap-
proaches to PC involving CWT, SBT and “drug holidays” (i.e. years without PC). The gaining
and sustaining SCORE study protocol and baseline characteristics have been described else-
where [18–21]. The primary research question presented here is which strategy for PC pro-
vided the greatest reduction in prevalence and intensity of S. haematobium infection among
9-to-12-year olds after four years of intervention in Cabo Delgado, Northern Mozambique. In
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addition, the impact of treatment on first-year students and adults sampled in each village was
also assessed. These findings will provide an evidence base for the Mozambique national con-
trol programme for schistosomiasis to address strategic questions about schistosomiasis treat-
ment and potentially shift from morbidity control to interruption of transmission, and
subsequently elimination.
Methods
Study arms
This study was a parallel cluster-randomised, intervention trial with six study arms (Fig 1).
Communities received various combinations of CWT, SBT or drug holiday over a four-year
period, with the final round of data collection carried out 12 months after Year 4 treatment.
All communities received CWT directly after Year 5 data collection, as they were no longer
participating in the trial. The most intensive intervention arm involves four years of CWT
(Arm 1), whilst the least intensive treatment strategy was two years of SBT PC followed by two
consecutive years of drug holidays (Arm 5).
Fig 1. Study arms for gaining control of Schistosomiasis Consortium for Operational Research and
Evaluation (SCORE) study [18]. There are six different potential study arms, where by each arm received a
four-year treatment strategy with varying combinations of community-wide treatment (CWT), school-based
treatment (SBT) and “drug holidays” (i.e. where no treatment is given): Arm 1: Annual CWT, Arm 2:
CWT-CWT- SBT-SBT, Arm 3: CWT-CWT- Holiday-Holiday, Arm 4: Annual SBT, Arm 5: SBT-SBT-Holiday-
Holiday, Arm 6: SBT-Holiday-SBT-Holiday.
https://doi.org/10.1371/journal.pntd.0006061.g001
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Study area and population
The area for this study was 10 out of 17 districts of Mozambique’s northern most province,
Cabo Delgado. The area was chosen as previous mapping had shown a high prevalence of S.
haematobium and a low prevalence of S. mansoni, as one of the country selection criteria was
no mixed infections to ensure that species type did not confound response to a particular treat-
ment strategy [18].
Communities to be included in the study were determined by convenience sampling based
on three criteria: (i) selecting only villages that had a primary school (so that it could be rando-
mised to SBT), (ii) village and school had no history of PC using PZQ against schistosomiasis,
(iii) and the village has a school attended by a minimum of 100 children aged 9-to-12-years.
Given that children who test positive must be treated, the eligibility survey was carried out
among fifty 13-to-14-year olds in each village, therefore treating those infected did not affect
subsequent study results, especially where prevalence was high [18]. The starting prevalence of
S. haematobium was evaluated by reagent strip testing for microhaematuria on a single mid-
day urine (communities were eligible only if21% by urine dipstick was detected) [22]. A
total of 150 communities found eligible were randomly assigned using a computer-based ran-
domisation procedure, without stratification, to one of the six study arms. Since the rainy sea-
son lasts from November to April, data were collected between July and October each year to
omit seasonal variation. A door-to-door census was conducted prior to treatment in Year 1 in
all selected communities to provide a baseline for estimating coverage.
Sample size
The aim was to enrol 25 villages per study arm, and to monitor each village’s prevalence and
intensity of S. haematobium infection among 100 school children aged 9-to-12-years. In each
school, 50 boys and 50 girls were selected using systematic random sampling from those in the
second, third and fourth classes. A total of 150 villages were enrolled, with 15,000 children
tested each year. Parasitological data were collected prior to treatment from Year 1 through to
Year 5. To evaluate the effect of treatment holidays, currently recommended by WHO PC
guidelines whereby moderate-risk communities are treated once every two years [7], no testing
of children was conducted during holiday years as children who were found to be infected
would have needed to be treated. Sample size calculations assumed treatment interventions
would reduce schistosomiasis prevalence in high endemicity areas from 50% in Year 1 to 15%
by the end of the study in the most intense treatment (Arm 1). Power computations used gen-
eralized estimating equations to fit a logistic regression model that included treatment arm
and time effects and treatment-by-time interaction, and assumed an over-dispersion parame-
ter of φ = 5.0. The minimum effect size was computed so that a difference over time could be
detected with 90% power for a 2-sided α = 0.05 level test. Negligible correlation was assumed
between variables in Year 1 and at study conclusion. Based on these assumptions, the calcula-
tions estimated that studying 25 villages per arm and 100 children per village were sufficient to
detect an overall difference between arms of 11.4% prevalence at the conclusion of the study.
In addition to children aged 9-to-12-years, systematic random sampling was used in each vil-
lage to select 100 first-year students (aged 5-to-8-years old) and a convenience sample of 50
adults (aged 20-to-55-years) in the first and fifth years only.
Urine examination
In each school, selected children were given a plastic pot labelled with an adhesive barcode
with unique identification numbers and asked to provide a single urine specimen. The sex,
age, and school class for each child were recorded. All samples were collected between 10am
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and 2pm and examined immediately in the school. Two filtrations of 10mL each were carried
out on a single urine sample using a nylon filter with a pore size of 20µm (Sefar AG; Heiden,
Switzerland) [23, 24]. Both filters were examined for S. haematobium eggs under a light micro-
scope and number of S. haematobium eggs were counted. All parasitological examinations
were performed by trained laboratory technicians. For quality control, around 10% of all
microscope slides were re-examined by a senior technician. The intensity of infection was
expressed as the number of eggs per 10mL of urine filtered. For specimens of less than 10 mL,
the volume of urine filtered was measured and the number of eggs per 10mL calculated. If esti-
mated counts were above 1,000 eggs per 10mL, they were truncated at 1,000. The arithmetic
mean of two filtrations taken from a single urine specimen was calculated to be the egg count
of the child [25]. A child was deemed egg positive if one or more eggs were found in any of the
slides examined.
Treatment
Praziquantel tablets were delivered at approximately 40mg/kg using a WHO dose pole [26].
All treatment was carried out in the village on the same day as sampling whereby everyone
was treated regardless of their parasitological results, which were anonymous. During SBT,
directly-observed treatment with PZQ was administered by trained teachers to all children
attending school. Efforts were made to treat non-school attendees through community sensiti-
sation and mobilisation efforts. CWT involved providing treatment to the entire eligible popu-
lation using community drug distributors either door-to-door or at fixed points in the study
community, which only excluded children under 4 years of age or under 94 cm in height.
Everyone who had taken the medication in SBT was monitored for adverse events for four
hours after treatment, since the analysis was carried out in the school. In the CWT, since the
drug distributor lives in the village they were available in the community.
At baseline (Year 1) a census was carried out in all selected communities of the total popula-
tion and proportion of all SAC (aged 5-14-years) recorded in the population to provide a base-
line for estimating coverage.
Ethical statement
Informed consent was obtained from all individuals18 years of age and from parents or legal
guardians of children less than 18 years of age. The purpose of the study was explained to all
schoolchildren and verbal assent was obtained from the children. Permission was also obtained
from school headmasters. Ethical clearance was obtained from the National Bio-ethical Com-
mittee for Health of Mozambique (NBCHM), and the survey was conducted according to
NBCHM guidelines (reference no. IRB00002657). The trial is registered with the International
Standard Randomised Controlled Trial registry under ISRTC number 14117624 for Mozam-
bique. The study protocol was also approved by Imperial College London (ICREC_10_2_2).
Data handling and analysis
Demographic data were collected on smartphones and uploaded to a dedicated database main-
tained on a central server (EpiCollect at Imperial College London). Laboratory data were col-
lected on paper forms and entered onto the smartphone retrospectively using the barcode with
unique identification number to link with the individual’s demographic information. The elec-
tronic data capture system involved entering data in the field, synching the data to a central
server and downloading the data retrospectively for cleaning and analysis. Data cleaning and
management was carried out by biostatisticians at the Schistosomiasis Control Initiative (SCI).
Data analysis was performed using R version 3.2 (R Core Team (2013): R: A language and
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environment for statistical computing. R Foundation for Statistical Computing, Vienna,
Austria).
Since 9-to-12-year olds are the only age group to be consistently sampled from baseline to
Year 5, the primary research question presented here is which strategy for PC provided the
greatest reduction in prevalence and intensity of S. haematobium infection among 9-to-
12-year olds after four years of intervention. In addition, the impact of treatment on first-year
students and adults have also been reviewed and analysed.
Individuals without data on age, sex, and presence or absence of eggs on at least one slide
were not included in the study. For each year of data, three infection categories for S. haemato-
bium infection were created: no infection, light infection (<50 eggs/10mL of urine), and heavy
infection (50 eggs/10mL of urine) [7]. Indicator variables were created for infection status
(0 = not infected, 1 = infected) and heavy infection status (0 = egg count <50, 1 = egg count>
50). These were averaged across each village to produce a village level prevalence and village
level prevalence of heavy infected, respectively. 95% confidence intervals were calculated for
village and study arm level prevalence values. Survey package [27] was used to consider survey
design effects. Prevalence of infection and heavy infection was calculated as arithmetic means
of the infection categories, aggregated by the relevant factors (e.g. age, sex). The arithmetic
mean of infection intensity was calculated using both egg positive and negative, aggregated by
grouping factors (village, study arm and gender). Although, mean intensity was underesti-
mated as egg counts were capped at 1000 eggs/10mL, this was done consistently over the years
therefore the trend in intensity change is believed to be valid. The egg reduction rate was calcu-
lated as the reduction in the intensity of infection assessed indirectly, using egg count via the
following formula: % egg = 10mL reduction (1−arithmetric mean of eggs/10mL urine after
treatment in Year 5) x 100 arithmetic mean of eggs = 10mL urine before treatment at Baseline.
To assess overall population-level programmatic impact on the prevalence of S. haemato-
bium between study arms, as per the standard analysis plan, agreed prior to analysis, General-
ised Estimated Equations (GEE) were used to estimate the differences between arms in year 5
only; unadjusted estimates using only village and study arm as covariates and adjusted esti-
mates including sex, age and weighting for number of children who provided data were mod-
elled using SAS software 9.1.2. (SAS Institute Inc., Cary, NC, USA). The models were run on
the three cross-sections of data: 9-to-12-year olds, first-year students (5-to-8-year olds), and
adults (20-to-55-year olds). Prevalence was modelled using a binomial GEE with logit link
function with Village IDs treated as the repeated measure and ‘Lsmestimate’ used to test pre-
specified differences between arms. In some villages, the enrollment was less than the target
study population size. To account for this, a village-weight term was added to the GEE model
to weight results according to numbers of children tested per village. Mean number of eggs per
10mL urine (mean intensity of infection) was modelled with negative-binomial GEE and log
link function. To avoid issues of multiple testing we focused on specific arm comparisons.
These comparisons were: Arm 1 (cccc) vs Arm 2 (ccss), Arm 1 (cccc) vs Arm 3 (cchh), Arm 1
(cccc) vs Arm 4 (ssss), Arm 4 (ssss) vs Arm 5 (sshh), and Arm 4 (ssss) vs Arm 6 (shsh) (Fig 1).
To assess the significance of the observed reduction in prevalence of S. haematobium in
adults in the SBT arms (4, 5, and 6) we performed a binomial Generalised Linear Mixed Model
(GLMM) with logit link function with infection status (0/1) as the response, age (standard-
ised), sex, study arm and study year as fixed effects and village as a random effect on a subset
of the parasitological data including only adults in the school based study arms for Year 1 and
Year 5.
Nominal treatment coverage stipulated in the study protocol was 75%. In practice this
was not achieved in many places. Despite additional data collection and considerable analytical
effort, we were unable to adequately validate coverage; for this reason further analysis
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incorporating treatment coverage would be inappropriate. As the issues appear to be consis-
tent throughout the study villages, the randomised allocation of villages to study arms means
between arm comparisons could still have validity.
Kulldorff’s space-time scan statistics were used to detect high-risk spatial clusters for schis-
tosomiasis infection using the SatScan software version 9.1.1. (Information Management Ser-
vices, Inc., Boston, MA, USA; www.satscan.org) [28, 29]. To detect the high-risk spatial
clusters of cases, the statistics use a moving elliptical window scanning the study area, and the
maximum size of which is no more than 50% of the total population. We reported statistically
significant clusters with an indicated p value <0.05. The SaTScan program was used to obtain
reported observed cases, expected cases, relative risk of infection, and locations of specific
cluster.
Results
Data were collected in the dry season between July and October each year from 2011 until
2015 in ten districts of Cabo Delgado province, Northern Mozambique. It was intended to
sample 105,000 people from a total of 150 villages over the five years, but due to poor school
enrolment and absence from many villages by children and adults working in the fields and
mines, our final analysis included 81,167 individuals (77.3% participation). One village
dropped out of the study prior to data collection due to political issues, therefore data is avail-
able from 149 villages.
Change in village-level prevalence from baseline to Year 5 is shown in Fig 2 and the SatScan
in S1 Fig. Overall, forty-three percent of the population was female. Prevalence of infection
decreased from baseline (60.5%) to Year 5 (38.8%), with prevalence of heavy infection also fall-
ing from 17.6% at baseline to 11.9% in Year 5 (Table 1). The change in prevalence of infection
across each individual community over time by study arm has been summarised in the S2 Fig.
Mean intensity of infection decreased from Year 1 to Year 2 but increases by Year 5. It appears
therefore that although the number of individuals infected reduces over time, the burden of
infection among infected individuals seem to be heavier. Study sample characteristics are sum-
marised in Table 1 for gender, prevalence and intensity of infection across all age groups from
baseline to Year 5.
9-to-12-year old cross-section
Over five years, 42,731 independent observations were taken of children aged 9-to-12 years
from 149 communities randomly allocated across six study arms. See S1 Table for a summary
of S. haematobium infection rates for each study year and study arm (9-to-12-year olds only).
The results in Table 2 and Fig 2 demonstrate the impact of treatment strategy on the preva-
lence and proportion of heavy infection of S. haematobium for the 9-to-12-year olds at baseline
and Year 5. The initial prevalence of S. haematobium infection was 66.7% across all study arms
for this age group, with 22.8% prevalence of heavy intensity of infection. Our findings show a
reduction in Year 5 where S. haematobium infection decreased to 42.5% over all treatment
arms and the proportion of those heavily infected reduced to 13.4%. The arithmetic mean
intensity of infection at the village level, reduced over the course of the study from 69.1 eggs
per 10ml urine to 58.1 eggs per 10ml, with changes in mean intensity between the study arms.
The egg reduction rate from baseline to Year 5 was 13.5% (Table 2).
Fig 3 shows the change in overall prevalence over time from the start of the project at base-
line to the final Year 5 in each community across the 10 districts of the study. In both Arms 3
(cchh) and 5 (sshh) there are two consecutive years of a break in treatment (“Holiday”) in
Years 3 and 4, following which there was an increase in prevalence and heavy intensity.
Impact of different treatment approaches on urogenital schistosomiasis
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Fig 2. S. haematobium village-level prevalence across the ten survey districts in Cabo Delgado at baseline and Year 5. The S. haematobium
prevalence of each village has been colour coded on the map according to level of prevalence. At baseline there are a greater number of higher
prevalence (coded dark red), particularly in those areas furthest from the coast. At Year 5, the prevalence levels of each village have been reduced
(coded yellow and orange) across all districts and areas of the map. We created the map ourselves using QGIS and publicly available shapefiles from
http://www.diva-gis.org/gdata" to the figure caption in the manuscript.
https://doi.org/10.1371/journal.pntd.0006061.g002
Table 1. Sample characteristics by study year for all individuals (first-year students, 9-12-year olds, and adults inclusive) examined.
Year No. of individuals
sampled
Proportion female
(%)
No. infected with S.
haematobium (%)
No. with heavy intensity of
infection (%)
Arithmetic
mean *
1
(2011)
21,571 7,866 (36.5) 13,049 (60.5) 3,796 (17.6) 51.3
2
(2012)
10,424 4,291 (41.2) 5,086 (48.8) 1,157 (11.1) 33.8
3
(2013)
8,632 4,922 (57.0) 3,569 (41.4) 514 (5.95) 36.8
4
(2014)
7,174 3,224 (45.0) 2,985 (41.6) 776 (10.8) 37.3
5
(2015)
33,366 12,291 (36.8) 12,937 (38.8) 3,961 (11.9) 53.0
* This is the mean egg count among egg-positive subjects tested in each year of the study, which is an estimate of the intensity of infection among known
active cases at each year of the study.
https://doi.org/10.1371/journal.pntd.0006061.t001
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Prevalence by gender demonstrated a higher prevalence of infection, as well as a greater
proportion of those heavily infected, among males (p<0.001) (Table 3). Response to treatment
was similar by gender, with both males and females showing reduced infection over time
across all arms, except for Arms 3 and 5 (Fig 4). Thus, prevalence and intensity of infection
appears to have increased after the treatment hiatus. The effects of treatment were analysed
using Arm 1, the most frequent and wide treatment approach, as the reference case. Arm 1
(annual CWT), had a comparable impact on prevalence as the less intense Arm 6 (SBT every
two years). Arm 1 had a greater reduction on prevalence than Arm 2, 3 and 4 across all years,
although the difference was not statistically significant (Table 3). Arm 1 did have a significantly
larger impact on S. haematobium infection than Arm 5 in Year 5 (p<0.024).
Significance testing to assess whether the prevalence of S. haematobium varied over time
between study arms showed that gender (p<0.001) and age (p<0.001) had a significant effect
on infection status with higher prevalence and proportion of those heavily infected seen in
males and among the 9-to-12-year age group in Year 5 (Table 3 and S2 Table). Across study
year, prevalence of infection significantly decreases over the five years (p<0.001) with no sta-
tistically significant effect across the study arms. For the SBT arms, Arm 4 (annual SBT) was
used as the reference arm to assess the impact of treatment holidays on prevalence. There was
no significant difference seen following holidays. The impact of four versus two treatments
was also assessed with the GEE model, where four treatments over four years (for both CWT
and SBT) had a significantly greater impact in reducing prevalence of infection (p<0.024)
Table 2. Summary of S. haematobium infection from Baseline to Year 5 and study arm (9-to-12-year cross-section only).
Variable Arm 1
(cccc)
Arm 2
(ccss)
Arm 3
(cshh)
Arm 4
(ssss)
Arm 5
(sshh)
Arm 6
(shsh)
Total/
Average
No. tested at baseline 1,270 1,081 1,208 1,421 1,287 962 7,229
No. infected at baseline 895 720 746 877 885 678 4,801
Prevalence at baseline (%) 70.5 66.6 61.8 61.7 68.8 70.5 66.7
Prevalence of heavy infection at baseline (%) 24.8 21.8 20.6 17.5 23.8 28.5 22.8
No. tested at Year 5 2,329 2,345 2,112 2,346 2,326 2,168 13,626
No. infected at Year 5 882 938 989 892 1210 871 5,782
Prevalence at Year 5 (%) 37.9 40.0 46.8 38.0 52.0 40.2 42.5
Prevalence of heavy infection at Year 5 (%) 10.4 11.9 15.9 13.1 17.5 11.6 13.4
Absolute difference between prevalence at Year 5 and
baseline
-32.6 -26.6 -15.0 -23.7 -16.8 -30.3 -24.2
Relative difference between prevalence at Year 5 and
baseline (% change)
-46.2 -39.9 -24.3 -38.4 -24.4 -43.0 -36.0
Village-level arithmetic mean infection intensity at baseline* 77.8 77.0 71.9 47.3 70.9 69.8 69.1
Village-level arithmetic mean infection intensity at Year 5* 40.5 53.3 71.9 55.2 77.0 50.3 58.1
Egg reduction rate (1-Year 5 intensity/baseline) 47.9% 30.8% -0.1% -16.9% -8.6% 28.0% 13.5%
Individual-level arithmetic mean infection intensity at
baseline**
81.6 79.5 80.4 52.9 63.8 80.8 73.2
Individual-level arithmetic mean infection intensity at Year 5
**
39.0 67.7 76.2 68.4 81.5 69.1 67.0
* Village-level intensity: This is the mean egg count for all tested 9-12-year-old subjects (including those with zero egg counts), which is a measure of
community level contamination potential
** Individual-level intensity: This is the mean egg count among egg-positive subjects, which is an estimate of the intensity of infection among known active
cases
cccc = annual CWT; ccss = CWT-CWT-SBT-SBT; cchh = CWT-CWT-Holiday-Holiday; ssss = Annual SBT; sshh = SBT-SBT-Holiday-Holiday;
shsh = SBT-Holiday-SBT-Holiday
https://doi.org/10.1371/journal.pntd.0006061.t002
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than two treatments over four years. There was no significant impact between the rounds of
treatment and intensity of infection (S3 Table).
Other age cross sections
In Year 1 and 5 of the study an additional 31,542 observations were recorded for first-year stu-
dents (aged 5-to-8-years) and 50 adults (aged 20-to-55-years) (Table 4). At baseline, examina-
tion revealed that of the 7,456 first-year students, 62.8% were infected with S. haematobium
and out of 4,253 adults, 44.5% were found to be infected. The proportion of heavily infected
first-year students was higher compared to adults, with 19.3% and 7.1%, respectively. In Year 5
prevalence had fallen to 39.3% and 26.4% among first-year students and adults, respectively,
and proportion of heavily infected had decreased to 12.8% and 5.6%, respectively.
Significance testing to assess whether the prevalence of S. haematobium differed between
study arms across the first-year students and adults in Year 5 are shown in Table 3 and S4
Table. From the GEE prevalence models adjusted for age and sex, gender was a significant
Fig 3. Prevalence of S. haematobium infection and heavy infection (dashed) by treatment over time (9–12 year-old-cross section only)
and by study arm with 95% CI. Each graph shows the change in prevalence of S. haematobium infection at each time point from baseline to
Year 5 by study arm, with heavy intensity of infection also marked on the graph. Prevalence and heavy infection levels decrease over time in all
arms, with the exception of arm 3 and 5 following two consecutive holiday years where infection levels appear to increase where communities
were not treated for a two year period.
https://doi.org/10.1371/journal.pntd.0006061.g003
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effect in first-students only (p<0.001) with males displaying a higher probability of being
infected than females. Increasing age was also significantly associated with infection among
first-year students, with the oldest respondents (8 years) being more likely to be infected than
seven and six-year olds (p<0.001). There was no statistical association between age or sex with
risk of infection in adults. For first-year students and adults, both the adjusted and unadjusted
prevalence models show no significant difference in prevalence between the study arms at the
end of the study.
Of particular interest is the statistically significant reduction in prevalence of infection for
adults from Year 1 to 5 in the SBT arms (Fig 5). Adults did not receive treatment in these
arms, however, the GEE prevalence model shows no significant difference in prevalence for
adult’s focal comparison arms. This would suggest that SBT alone has an impact on disease
transmission.
Treatment coverage by strategy over time
Drug coverage was defined as the proportion of individuals who have ingested the PZQ [7].
The denominator is the estimated target population. The SBT coverage was determined by the
Table 3. GEE logistic model to assess differences in prevalence and intensity of S. haematobium infection between Year 1 and Year 5 and between
study arms for each cross-section (33,459 Observations).
Difference in Prevalence
unadjusted
Difference in Prevalence
adjusted
Difference in Intensity
unadjusted
Difference in Intensity
adjusted
Age group Arm
comparison
Estimate (95% CI) Pr > |z| Estimate (95% CI) Pr > |z| Estimate (95% CI) Pr > |z| Estimate (95% CI) Pr > |z|
9-to-12-year
olds
arm 2 vs. arm 1 0.054
(-0.385,0.493)
0.809 0.08
(-0.365,0.526)
0.724 0.49
(-0.148,1.128)
0.132 0.446
(-0.273,1.166)
0.224
arm 3 vs. arm 1 0.351
(-0.154,0.856)
0.173 0.372
(-0.161,0.905)
0.172 0.668
(0.073,1.263)
0.028 0.765
(0.099,1.432)
0.025
arm 4 vs. arm 1 -0.022
(-0.512,0.469)
0.931 0.015
(-0.474,0.503)
0.953 0.507
(-0.189,1.202)
0.153 0.485
(-0.306,1.276)
0.229
arm 5 vs. arm 4 0.547
(0.085,1.009)
0.020 0.547
(0.073,1.021)
0.024 0.273
(-0.409,0.954)
0.433 0.274
(-0.41,0.959)
0.432
arm 6 vs. arm 4 0.127
(-0.401,0.655)
0.637 0.115
(-0.471,0.701)
0.701 -0.03
(-0.734,0.674)
0.934 -0.352
(1.127,0.423)
0.374
20-to-55-year
olds
arm 2 vs. arm 1 0.096
(-0.325,0.516)
0.656 0.162
(-0.594,0.919)
0.674 -0.325
(1.034,0.384)
0.368 -0.24
(-0.949,0.469)
0.508
arm 3 vs. arm 1 0.11 (-0.392,0.611) 0.668 -0.023
(0.559,0.512)
0.932 0.315
(-0.605,1.234)
0.502 0.388
(-0.512,1.288)
0.398
arm 4 vs. arm 1 0.338
(-0.076,0.753)
0.109 0.315
(-0.158,0.787)
0.192 0.72
(-0.115,1.555)
0.091 0.704
(-0.068,1.476)
0.074
arm 5 vs. arm 4 0.188
(-0.274,0.651)
0.425 0.111
(-0.36,0.581)
0.645 -0.2 (-1.08,0.681) 0.657 -0.398
(1.193,0.397)
0.327
arm 6 vs. arm 4 0.008
(-0.528,0.544)
0.977 -0.204
(0.763,0.355)
0.474 -0.635
(-1.52,0.251)
0.160 -0.98 (-1.914,-
0.046)
0.040
5-to-8-year olds arm 2 vs. arm 1 -0.066
(-0.547,0.414)
0.788 -0.192
(0.762,0.378)
0.509 -0.117
(0.749,0.516)
0.718 -0.576
(1.668,0.517)
0.302
arm 3 vs. arm 1 0.245
(-0.344,0.834)
0.415 0.119
(-0.564,0.803)
0.732 0.698
(-0.033,1.428)
0.061 0.778
(-0.227,1.784)
0.129
arm 4 vs. arm 1 0.016
(-0.532,0.563)
0.955 -0.09
(-0.644,0.465)
0.751 0.373
(-0.497,1.243)
0.400 0.187
(-0.651,1.025)
0.662
arm 5 vs. arm 4 0.48 (-0.011,0.97) 0.050 0.422 (-0.1,0.944) 0.113 0.136
(-0.708,0.98)
0.752 0.128
(-0.72,0.975)
0.768
arm 6 vs. arm 4 0.024 (-0.53,0.578) 0.932 0.021
(-0.643,0.686)
0.950 -0.143
(1.093,0.806)
0.767 -0.341
(1.229,0.547)
0.451
https://doi.org/10.1371/journal.pntd.0006061.t003
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percentage of school-aged children (5-12-years) that were treated, including those not enrolled
in school. CWT coverage was determined by the total population treated using a denominator
of the whole population based on the census carried out by the SCORE study in 2011. Cover-
age by study arm for each year is outlined in Table 5.
The nominal treatment coverage stipulated by the study protocol was coverage of more
than 75% for both SBT and CWT [7], which did not occur in many communities due to sus-
pected inaccuracies in denominator values. The results shown in Table 5 shows that SBT cov-
erage remained consistently low over time across all arms. CWT coverage, however, did
increase over time across all arms, with no significant difference seen between arms.
When coverage was put into the multivariate model looking at impact on changes of preva-
lence over time, there was no clear trend or significant relationship with impact on infection.
Financial costs of different treatment strategies
Delivery costs (defined as the cost per person treated minus the drug costs) was $0.31 for SBT
and $0.36 for CWT. The relative costs by each activity and input are summarised in Table 6.
Our cost-analysis does not consider unpaid days of labour for individuals such as teachers, or
Fig 4. Prevalence of S. haematobium infection and heavy infection (dashed) by treatment by gender (males = blue and females = red)
over time and study arm for 9–12 year-old-cross section. Each graph shows the change in prevalence of S. haematobium infection at each
time point from baseline to Year 5 by study arm, with heavy intensity of infection also marked on the graph, separated by gender. There was no
difference in response to treatment by gender, with both boys and girls’ prevalence and heavy infection levels decreasing over time in all arms,
with the exception of arm 3 and 5 following two consecutive holiday years where infection levels increase.
https://doi.org/10.1371/journal.pntd.0006061.g004
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other costs related to the SCORE field work. When the financial costs were broken down by
activity, there was substantial cost saving for SBT for supervision and monitoring as this was
carried out by the SCORE field teams during the prevalence survey. For CWT on the other
hand, additional costs were incurred as supervisors were sent back to the villages post-survey
to supervise and collect treatment registers.
According to input costs, there was a greater cost in per diems due to additional costs of
community drug distributors salary and incentives (where one distributor was recruited for
every 500 people in the village), whereas teachers were not paid extra in the schools but given
incentives (a t-shirt) only. Fuel costs were also higher for CWT since the teams needed to re-
visit the communities a second time to collect any left-over drugs and the treatment registers.
In SBT the treatment was done on the same day as the prevalence survey and the registers
taken. The additional material costs for CWT were incurred due to additional treatment regis-
ters printed for larger numbers being treated.
Discussion
In Cabo Delgado, Mozambique, S. haematobium infection was found prevalent throughout all
149 schools in the study, where many schools had 90% baseline prevalence (Fig 2). The pri-
mary outcome of the study was to examine the change in infection among 9-to-12-year olds
between specified study arms. Our findings showed a significant decrease in S. haematobium
infection in this age group from a mean prevalence of 66.4% in Year 1 (of which 22.5% were
heavily infected) to 42.5% in Year 5 (when 13.4% were heavily infected). When comparing the
impact of treatment strategy each year, the only significant response to study arm was seen
between annual SBT (arm 4) and two years of SBT followed by two consecutive treatment holi-
days (arm 5), which resulted in a higher final prevalence than when there were no treatment
Table 4. Summary of S. haematobium infection for years 1 and 5 by study arm (first-year students and adults).
Year Arm First year students (5-8-years) Adults (20-55-years)
Number
tested
Number
infected (%)
Heavily
infected (%)
Mean infection
intensity
Number
tested
Number
infected (%)
Heavily
infected (%)
Mean infection
intensity
1 1 1,419 846 (59.6) 239 (16.8) 50.0 735 351 (47.8) 64 (8.7) 25.5
2 1,148 751 (65.4) 239 (20.8) 66.1 615 328 (53.3) 60 (9.8) 33.5
3 1,465 913 (62.3) 291 (19.9) 68.0 890 367 (41.2) 51 (5.1) 23.2
4 1,296 765 (59.0) 189 (14.6) 42.0 652 210 (32.2) 33 (5.1) 16.6
5 1,191 823 (69.1) 247 (20.7) 64.2 703 373 (53.1) 59 (8.4) 29.3
6 937 586 (62.5) 234 (25) 59.3 658 265 (40.3) 33 (5.0) 15.2
Total 7,456 4,684 (62.8) 1,439 (19.3) 58.1 4,253 1,894 (44.5) 300 (7.1) 23.9
5 1 2,251 808 (35.9) 262 (11.6) 46.6 1,151 247 (21.5) 49 (4.3) 20.2
2 2,282 785 (34.4) 215 (9.4) 41.5 1,008 230 (22.8) 43 (4.3) 14.4
3 2,069 893 (43.2) 337 (16.3) 84.8 1,181 287 (24.3) 64 (5.4) 27.8
4 2,320 845 (36.4) 287 (12.4) 63.3 1,085 311 (28.7) 93 (8.6) 40.6
5 2,205 1,085 (49.2) 369 (16.7) 77.5 1,084 357 (32.9) 71 (6.5) 34.1
6 2,117 784 (37.0) 224 (10.6) 60.0 1,080 308 (28.5) 50 (4.6) 21.5
Total 13,244 5,200 (39.3) 1,694 (12.8) 61.8 6,589 1,740 (26.4) 370 (5.6) 26.5
Absolute
difference in
prevalence?
-23.5 -18.1
Relative
difference in
prevalence?
-37.4 -40.7
https://doi.org/10.1371/journal.pntd.0006061.t004
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Fig 5. Prevalence of S. haematobium infection and mean intensity by study arm at baseline and Year 5 for first-year students (aged 5-
8-years) and adult cross section. Each graph shows the change in prevalence of S. haematobium infection and mean intensity, at baseline
and Year 5, separated by study arm. There was large reduction in prevalence in both first-year students and adults from baseline to Year 5
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holidays. There were no significant differences in Year 5 prevalence for the other treatment
comparisons. The general uptrend in prevalence and intensity of S. haematobium infection
shown after two subsequent holiday years, compared with one-year post-treatment, demon-
strates rebound of S. haematobium if PC is interrupted. These findings of significant risk for
re-emergence of infection if treatment is suspended supports previous schistosome infection
modelling [30, 31].
Other studies have shown that the highest prevalence and intensities of infection occurred
in males and among the 9-to-12-year age group, with infection decreasing in adulthood [32–
36]. Despite a higher starting prevalence in adolescent males, there was no statistically signifi-
cant difference in response to treatment by gender or age across the study arms. There is a
need to explore further whether boys in these regions are more susceptible to subtle morbidity
and impaired growth, mental or physical performance than girls.
The limitations of the current diagnostic methods for urogenital schistosomiasis have been
demonstrated elsewhere, where the current ‘gold standard’ of urine filtration has been shown
across all study arms. Mean intensity of infection decreased in first-year students and adults in arm 1 and 2 only. In the remaining study arms (3–
6), mean intensity levels increase from baseline to Year 5 in both first-year students and adults. It appears therefore that although the number of
individuals infected reduces over time, the burden of infection in infected individuals seem to be heavier. It is not clear whether individuals
harbouring a high parasite burden in such highly endemic populations are being re-infected each year, are more likely to be non-compliant in
terms of taking the treatment, or if the parasites have developed resistance to treatment.
https://doi.org/10.1371/journal.pntd.0006061.g005
Table 5. Treatment numbers and percentage coverage by study arm for each year.
SBT coverage CWT coverage
Study Arm
SAC treated SAC total for treatment % SAC treated Total number treated Total CWT for treatment % total CWT treated
Year 1
1 (cccc) CWT given in Year 1 in Arms 1–3 20,284 70,495 28.8%
2 (ccss) 16,692 71,728 23.3%
3 (cshh) 19,687 50,559 38.9%
4 (ssss) 7,661 24,804 30.9% 8,139 SBT given in Year 1 in Arms 4–6
5 (sshh) 7,039 24,022 29.3% 7,292
6 (shsh) 6,421 24,297 26.4% 6,494
Year 2*
1 (cccc) CWT given in Year 2 in Arms 1–2 31,505 70,495 44.7%
2 (ccss) 25,486 71,728 35.5%
3 (cshh) 7,998 13,609 58.8% 21,047 SBT given in Year 2 in Arms 3–5
4 (ssss) 5,638 24,804 22.7% 6,478
5 (sshh) 7,764 22,193 35.0% 8,186
Year 3*
1 (cccc) CWT given in Year 3 in Arms 1 37,858 70,495 53.7%
2 (ccss) 7,239 21,518 33.6% 7,658 SBT given in Year 3 in Arms 2, 4 and 6
4 (ssss) 543 966 56.2% 651
6 (shsh) 6,617 24,297 27.2% 7,671
Year 4*
1 (cccc) CWT given in Year 3 in Arms 1 91,530 70,495 129.8%
2 (ccss) 5,812 21,518 27.0% 5,977 SBT given in Year 3 in Arms 2 and 4
4 (ssss) 5,648 24,804 22.8% 5,786
*Arms with treatment holidays do not have treatment data in these years.
https://doi.org/10.1371/journal.pntd.0006061.t005
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to be insensitive, especially in areas with low endemicity, and egg secretion varies from day-to-
day [37, 38]. However, in the context of Cabo Delgado where the prevalence and intensity of
infection even in Year 5 remained high, it is likely that infections were not underestimated.
Furthermore, aim of this study is to look at relative reduction in infection over time and given
that microscopy was done consistently over the years, the trend in change is believed to be
valid.
As shown in the SatScan spatial scan, there is a decrease in the number of high prevalence
spatial clusters from two western clusters at baseline to a single and less scattered central clus-
ter in Year 5. A possible explanation for this is that as the prevalence of infection decreases
over time, heterogeneities in the force of transmission by geography or social group become
more visible. Such geographical clustering has also been seen in other SCORE projects in
Kenya [39]. Further research is therefore necessary to understand how transmission dynamics
change by space and social group as prevalence reduces, particularly among more resilient
places/groups, and therefore how to adapt interventions accordingly.
There is a growing body of evidence demonstrating the burden of infection and morbidity
in adults, as well as their potential role in sustaining transmission [14, 30, 31, 40–42]. Indeed,
the results here show that in arms 3–6 mean intensity levels increase from baseline to Year 5 in
adults. It appears that although the number of individuals infected reduces over time, the bur-
den of infection in those infected seem to be heavier. It is not clear whether individuals har-
bouring a high parasite burden in such highly endemic populations are being re-infected each
year, are non-compliant in taking the treatment, or if the parasites have developed resistance
to treatment. This implies a greater need to include adults in schistosomiasis PC treatment
programmes in some endemic settings. The SCORE study is therefore crucial as it investigates
the impact of CWT in reaching more adults. The findings from Mozambique, however, have
Table 6. Financial costs of treatment strategy.
Cost by Activity CWT SBT
Training $236.79 $133.23
Advocacy $290.00 $290.00
Supervision/Monitoring $102.31 $3.60
Drug Distribution & Coverage $691.19 $302.30
TOTAL $1,320.30 $729.13
Cost by Input CWT SBT
Per diem Ξ $818.00 $365.00
Vehicle Maintenance $268.00 $268.00
Fuel $132.47 $57.75
Materials* $101.83 $38.38
TOTAL $1,320.30 $729.13
Total cost per person treated CWT SBT
Total Cost $1,320.30 $729.13
Cost/Village $264.06 $159.23
Average number treated in Year 4 3661 874
Cost/Person treated $0.36 $0.31
Ξ Per diems include national (coordinators and technical staff), district and regional health and educational
staff, and community level staff including community drug distributors, teachers, community health workers
etc.
*Materials include Phone cards, information/education/communication posters, treatment registers, dose
poles etc.
https://doi.org/10.1371/journal.pntd.0006061.t006
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demonstrated a significant reduction in prevalence of schistosomiasis in adults even in the
SBT arms, implying transmission in the community has been decreased, even where only
school children have been treated. These results support previous findings that demontrates
the potential benefit of switching to community-wide mass treatment is highly variable in dif-
ferent contexts [43, 44]. The delivery cost for SBT and CWT in this SCORE study is summa-
rised in the Table 6 where $0.31 was calculated for SBT and $0.36 for CWT per person treated.
Although this difference is small on an individual basis, in 2016 the Mozambique Ministry of
Health treated around 8.5 million people and therefore these results therefore have significant
logistical and cost-saving implications for a national control programme as they challenge the
justification for CWT. Furthermore, a crude analysis of the relative cost per person treated by
percentage reduction in infection for each study arm implies that even though two treatments
over five years reduces prevalence less than four treatments, two treatments has a greater per-
centage reduction by relative cost.
Village-level data, both in communities and at the school, were collected about water
sources, sanitation, and hygiene (WaSH) issues through key-informant interviews. The base-
line results from the WaSH survey have been published elsewhere [21]. In brief, among our
study population, use of open surface water was widely reported for washing and bathing, and
although pit latrines were reported to exist in most communities, open urination was widely
practised. Furthermore, nearly all the communities in this study rely on subsistence farming
whereby a large proportion of villagers spend months at a time sleeping in tented accommoda-
tion whilst working in the ‘machambas’ (fields), with no access to sanitation. Despite, such
reported high-risk behaviour when the WaSH data was incorporated into the multivariate
model, there were no significant findings associated with change in prevalence and intensity of
infection across the study arms.
The most plausible explanation for why more intense treatment approaches did not result
in a better impact on infection reduction was most likely due to poor treatment coverage. The
nominal treatment coverage stipulated by the protocol was more than 75% for both SBT and
CWT, which did not occur in many communities. A qualitative Knowledge Attitudes and
Practices (KAP) survey was carried out in Year 3 to understand the challenges to achieving suf-
ficient coverage, this showed contextual issues extraneous to the study that included extremely
low school attendance (around 30% in majority of communities), high proportion of individu-
als (including school-aged children) working in fields or mines during the day, acute flooding
which proved challenging to the CWT, severe political unrest and subsequent mistrust in any
health-related programmes following cholera outbreaks, and poor study sensitisation in some
areas. Although several days were spent by the survey team in each community to mobilise
inhabitants, many communities were sparsely populated for several weeks whilst people were
living in their fields or away in the mines for extended periods of time, which also highlighted
the issue of unreliable denominator data. Nevertheless, there was an increase in CWT coverage
over time that was due raised awareness of the programme and less trepidation in taking the
treatment as the programme progressed, distribution of t-shirts among key community indi-
viduals in Year 3 and in Year 4 food was provided free-of-charge with treatment to help
increase treatment coverage. Other studies have shown that provision of a pre-treatment snack
can result in reduced side-effects as well as decreased prevalence of schistosomiasis [45]. These
strategies proved effective with regards to community treatment coverage, but less impact on
school treatment coverage. Such challenges in attaining good coverage is a reality for national
control programmes, particularly in the light of poor school attendance [46]. There it is even
harder to achieve than in a study setting such as ours, where there are generally more time and
resources allocated to sensitising and motivating communities to participate.
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Conclusions
The results obtained show that Cabo Delgado province in Northern Mozambique is highly
endemic for urinary schistosomiasis. Although PC was successful in reducing the burden of
active infection in all study arms, a more intense treatment approach, such as annual CWT,
did not have as much impact as expected. This may be due to extremely high starting preva-
lence and intensity in the study area, with frequent exposure to reinfection [47]. It also may be
related to poor treatment coverage and the challenge of performing a long-term study in a
resource-poor setting, which may not be valid in other locations. These findings highlighted
the need to complement mass drug administration with extensive public health education and
behavioural modifications to reduce the risk of reinfection, and to consider the use of vector
control through mollusciciding in areas where compliance to treatment proves to be challeng-
ing [38, 48]. There is a need to explore further those individuals harbouring a high parasite
burden in such highly endemic populations to understand whether they are being re-infected
each year, are more likely to be non-compliant in terms of taking the treatment, or if the
parasites might have developed resistance to treatment. The results of this study have also
highlighted the challenge of achieving high treatment coverage especially with such highly
migrant communities, specifically acquiring accurate population figures, and the importance
of independent coverage surveys that do not rely on denominator values to accurately evaluate
the impact of a treatment programme. Furthermore, more frequent treatment had a greater
impact on prevalence of infection when arms were grouped by number of treatments, how-
ever, the costs efficiency was greater in arms only receiving two treatments. Finally, the signifi-
cant reduction in prevalence of schistosomiasis among adults even in the SBT Arms implying
transmission in the community has been decreased, has significant logistical and cost-saving
implications for a national control programme as they challenge the justification for CWT.
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S1 Fig. Spatial clusters of high prevalence villages calculated in SatScan. Spatial clusters of
high prevalence villages calculated in SatScan show a decrease in the number of disease clusters
from baseline (Year 1) to Year 5, and the spatial extent of disease became less scattered over
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